You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.
In Nature this week: missense variant linked to decreased height among Peruvians, genetic basis of sex-biased vulnerability to certain disorders, and more.
Under the expanded deal, PredictImmune will have first right of refusal on technologies for predicting disease outcome for systemic lupus erythematosus.
In PLOS this week: HLA-region changes linked to lupus risk among East Asians, epigenome-wide association study of maternal circadian rhythm, and more.
Somalogic will use its SomaScan platform to analyze at least 15,000 clinical samples from Janssen to identify protein biomarkers for various diseases.
PredictImmune's test relies on a 16-marker panel run using quantitative PCR to stratify Crohn's disease and ulcerative colitis patients according to the severity of their illnesses.
Cincinnati Children's Hospital Medical Center researchers found that disease risk loci overlap with transcription factor binding sites.
In Science this week: protein destabilizing mutations can drive evolution, and more.
The company is combining digital recruiting methods with at-home sample collection to speed up the study process.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.